Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fornerod

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Genes & Development|September 29, 1999
Luc7p, a novel yeast U1 snRNP protein with a role in 5' splice site recognitionP Fortes, D Bilbao-Cortés, M Fornerod, et al.
FEBS Letters|May 12, 2012
A new function of ROD1 in nonsense-mediated mRNA decayT F Brazão, J Demmers, W van IJcken, et al.
Bailliere'S Clinical Haematology|October 1, 1992
Translocation t(6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion geneM von Lindern, M Fornerod, N Soekarman, et al.
The EMBO Journal|February 17, 1997
The human homologue of yeast CRM1 is in a dynamic subcomplex with CAN/Nup214 and a novel nuclear pore component Nup88M Fornerod, J van Deursen, S van Baal, et al.
Human Gene Therapy|September 1, 1995
Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope proteinY Yang, E F Vanin, M A Whitt, et al.
Oncogene|May 4, 1995
Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangementsM Fornerod, J Boer, S van Baal, et al.
Molecular and Cellular Biology|August 24, 1999
RanGTP-regulated interactions of CRM1 with nucleoporins and a shuttling DEAD-box helicaseP Askjaer, A Bachi, M Wilm, et al.
Oncogene|July 14, 2015
miR-139-5p controls translation in myeloid leukemia through EIF4G2S Emmrich, F Engeland, M El-Khatib, et al.
Oncogene|September 12, 2017
MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AMLN S D Larmonie, T C J M Arentsen-Peters, A Obulkasim, et al.
Leukemia|November 26, 2013
miR-9 is a tumor suppressor in pediatric AML with t(8;21)S Emmrich, J E Katsman-Kuipers, K Henke, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Genes & Development|September 29, 1999
Luc7p, a novel yeast U1 snRNP protein with a role in 5' splice site recognitionP Fortes, D Bilbao-Cortés, M Fornerod, et al.
FEBS Letters|May 12, 2012
A new function of ROD1 in nonsense-mediated mRNA decayT F Brazão, J Demmers, W van IJcken, et al.
Bailliere'S Clinical Haematology|October 1, 1992
Translocation t(6;9) in acute non-lymphocytic leukaemia results in the formation of a DEK-CAN fusion geneM von Lindern, M Fornerod, N Soekarman, et al.
The EMBO Journal|February 17, 1997
The human homologue of yeast CRM1 is in a dynamic subcomplex with CAN/Nup214 and a novel nuclear pore component Nup88M Fornerod, J van Deursen, S van Baal, et al.
Human Gene Therapy|September 1, 1995
Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope proteinY Yang, E F Vanin, M A Whitt, et al.
Oncogene|May 4, 1995
Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangementsM Fornerod, J Boer, S van Baal, et al.
Molecular and Cellular Biology|August 24, 1999
RanGTP-regulated interactions of CRM1 with nucleoporins and a shuttling DEAD-box helicaseP Askjaer, A Bachi, M Wilm, et al.
Oncogene|July 14, 2015
miR-139-5p controls translation in myeloid leukemia through EIF4G2S Emmrich, F Engeland, M El-Khatib, et al.
Oncogene|September 12, 2017
MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AMLN S D Larmonie, T C J M Arentsen-Peters, A Obulkasim, et al.
Leukemia|November 26, 2013
miR-9 is a tumor suppressor in pediatric AML with t(8;21)S Emmrich, J E Katsman-Kuipers, K Henke, et al.
Pageof 4